insurance coverage for glp 1 for weight loss Medicaid of and Spending on GLP-1s are glp-1 drugs covered by

2025;28 doi: 10.1136/bmjment-2025-301635

Furthermore, we demonstrated in animal studies that GLP-1 secretion induced by these factors does not evoke aversive behaviors, unlike GLP-1RAs, and promotes satiation, thereby suppressing hyperphagia and weight gain induced by a high-fat diet

Braganza, A., Annarapu, G

Sales of Johnson and Johnsons blockbuster cancer drug Darzalex soared 18% year over year to $2.87 billion in the second quarter, helping the pharma giant outperform Wall Street expectations

Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction